893 related articles for article (PubMed ID: 21572395)
1. Immunogenicity of induced pluripotent stem cells.
Zhao T; Zhang ZN; Rong Z; Xu Y
Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395
[TBL] [Abstract][Full Text] [Related]
2. Stem cells: iPS cells under attack.
Apostolou E; Hochedlinger K
Nature; 2011 Jun; 474(7350):165-6. PubMed ID: 21654792
[No Abstract] [Full Text] [Related]
3. Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice.
Kim EM; Manzar G; Zavazava N
Immunology; 2017 Jun; 151(2):191-197. PubMed ID: 28185259
[TBL] [Abstract][Full Text] [Related]
4. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.
Guha P; Morgan JW; Mostoslavsky G; Rodrigues NP; Boyd AS
Cell Stem Cell; 2013 Apr; 12(4):407-12. PubMed ID: 23352605
[TBL] [Abstract][Full Text] [Related]
5. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
[TBL] [Abstract][Full Text] [Related]
6. Brief Report: Immune Microenvironment Determines the Immunogenicity of Induced Pluripotent Stem Cell Derivatives.
Todorova D; Kim J; Hamzeinejad S; He J; Xu Y
Stem Cells; 2016 Feb; 34(2):510-5. PubMed ID: 26439188
[TBL] [Abstract][Full Text] [Related]
7. Cells derived from iPSC can be immunogenic - yes or no?
Cao J; Li X; Lu X; Zhang C; Yu H; Zhao T
Protein Cell; 2014 Jan; 5(1):1-3. PubMed ID: 24474200
[TBL] [Abstract][Full Text] [Related]
8. Reduced immunogenicity of induced pluripotent stem cells derived from Sertoli cells.
Wang X; Qin J; Zhao RC; Zenke M
PLoS One; 2014; 9(8):e106110. PubMed ID: 25166861
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium.
Liu Z; Wen X; Wang H; Zhou J; Zhao M; Lin Q; Wang Y; Li J; Li D; Du Z; Yao A; Cao F; Wang C
PLoS One; 2013; 8(6):e66369. PubMed ID: 23840453
[TBL] [Abstract][Full Text] [Related]
10. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium.
Swijnenburg RJ; Tanaka M; Vogel H; Baker J; Kofidis T; Gunawan F; Lebl DR; Caffarelli AD; de Bruin JL; Fedoseyeva EV; Robbins RC
Circulation; 2005 Aug; 112(9 Suppl):I166-72. PubMed ID: 16159810
[TBL] [Abstract][Full Text] [Related]
11. Episomal Induced Pluripotent Stem Cells Promote Functional Recovery of Transected Murine Peripheral Nerve.
Loh CY; Wang AY; Kao HK; Cardona E; Chuang SH; Wei FC
PLoS One; 2016; 11(10):e0164696. PubMed ID: 27736950
[TBL] [Abstract][Full Text] [Related]
12. The immunogenicity of cells derived from induced pluripotent stem cells.
Fu X
Cell Mol Immunol; 2014 Jan; 11(1):14-6. PubMed ID: 24336164
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells.
Basma H; Gunji Y; Iwasawa S; Nelson A; Farid M; Ikari J; Liu X; Wang X; Michalski J; Smith L; Iqbal J; El Behery R; West W; Yelamanchili S; Rennard D; Holz O; Mueller KC; Magnussen H; Rabe K; Castaldi PJ; Rennard SI
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L552-65. PubMed ID: 24487392
[TBL] [Abstract][Full Text] [Related]
14. Genetic background affects induced pluripotent stem cell generation.
Schnabel LV; Abratte CM; Schimenti JC; Southard TL; Fortier LA
Stem Cell Res Ther; 2012 Aug; 3(4):30. PubMed ID: 22862934
[TBL] [Abstract][Full Text] [Related]
15. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
[TBL] [Abstract][Full Text] [Related]
16. Continuous expression of reprogramming factors induces and maintains mouse pluripotency without specific growth factors and signaling inhibitors.
Mao Y; Wang L; Zhong B; Yang N; Li Z; Cui T; Feng G; Li W; Zhang Y; Zhou Q
Cell Prolif; 2021 Aug; 54(8):e13090. PubMed ID: 34197016
[TBL] [Abstract][Full Text] [Related]
17. Study on the Extrapolability of Current Tumorgenicity Test With Mice by Comparing the Syngeneic or Allogeneic Mouse Transplantation Model.
Tamura T; Tahara T; Inoue M; Nanjo R; Onoe H; Yamamoto T; Kawamata S
Stem Cells Transl Med; 2024 Jun; 13(6):572-581. PubMed ID: 38554123
[TBL] [Abstract][Full Text] [Related]
18. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
[TBL] [Abstract][Full Text] [Related]
19. Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells.
Zhao T; Zhang ZN; Westenskow PD; Todorova D; Hu Z; Lin T; Rong Z; Kim J; He J; Wang M; Clegg DO; Yang YG; Zhang K; Friedlander M; Xu Y
Cell Stem Cell; 2015 Sep; 17(3):353-9. PubMed ID: 26299572
[TBL] [Abstract][Full Text] [Related]
20. Enhanced wound healing promotion by immune response-free monkey autologous iPSCs and exosomes vs. their allogeneic counterparts.
Lu M; Peng L; Ming X; Wang X; Cui A; Li Y; Wang X; Meng D; Sun N; Xiang M; Chen S
EBioMedicine; 2019 Apr; 42():443-457. PubMed ID: 30926422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
